Statement of Principles concerning mesangial IGA glomerulonephritis No. 64 of 2001

Administered by Department of Veterans' Affairs

Legislation au F2005B02766 Not in force Legislative Instrument

Legislation content

Instrument No.64 of 2001

 

Determination

of

Statement of Principles

concerning

MESANGIAL IGA GLOMERULONEPHRITIS

 

 

Veterans’ Entitlements Act 1986

 

 

1. This Statement of Principles is determined by the Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act).

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about mesangial IgA glomerulonephritis and death from mesangial IgA glomerulonephritis.

 

(b)              For the purposes of this Statement of Principles, “mesangial IgA glomerulonephritis” means a disease of the kidneys characterised by a predominance of immunohistologically proven IgA deposits in the renal mesangium and recurring and intermittent episodes of haematuria or proteinuria. This definition includes primary mesangial IgA glomerulonephritis and secondary mesangial IgA glomerulonephritis.

 

Basis for determining the factors

3. On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that mesangial IgA glomerulonephritis and death from mesangial IgA glomerulonephritis can be related to relevant service rendered by veterans or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must exist before it can be said mesangial IgA glomerulonephritis or death from mesangial IgA glomerulonephritis that, on the balance of probabilities, are connected with the circumstances of a person’s relevant service are:

 

(a)               for secondary mesangial IgA glomerulonephritis only, suffering from cirrhosis of the liver at the time of the clinical onset of mesangial IgA glomerulonephritis; or

 

(b)               for secondary mesangial IgA glomerulonephritis only, suffering from Schonlein-Henoch purpura at the time of the clinical onset of mesangial IgA glomerulonephritis; or

 

(c)              inability to obtain appropriate clinical management for mesangial IgA glomerulonephritis.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(c) applies only to material contribution to, or aggravation of, mesangial IgA glomerulonephritis where the person’s mesangial IgA glomerulonephritis was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8. For the purposes of this Statement of Principles:

 

“cirrhosis of the liver” means a pathologically defined entity involving irreversible chronic injury of the hepatic parenchyma and includes extensive fibrosis in association with regenerative nodules;


“death from mesangial IgA glomerulonephritis” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s mesangial IgA glomerulonephritis;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Second Edition, effective date of 1 July 2000, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 271 3;

 

“primary mesangial IgA glomerulonephritis” means predominant IgA mesangial deposits in the absence of clinical or laboratory evidence of any other associated systemic disease, and is also known as Berger's disease or idiopathic IgA nephropathy;

 

“relevant service” means:

 

(a) eligible war service (other than operational service); or

(b) defence service (other than hazardous service);

 

“Schonlein-Henoch purpura” means a systemic vasculitis affecting small calibre vessels, causing a characteristic clinical syndrome of vascular purpura in the lower limbs, abdominal pain, joint pain and nephritis;

 

“secondary mesangial IgA glomerulonephritis” means predominant IgA mesangial deposits in the presence of clinical or laboratory evidence of any other associated systemic disease;

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

(a) pneumonia;

(b) respiratory failure;

(c) cardiac arrest;

(d) circulatory failure; or

(e)               cessation of brain function;


 

 

Dated this Fourteenth day of  August  2001

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of    )

 

KEN DONALD

CHAIRMAN

Overview

The Statement of Principles concerning Mesangial IgA Glomerulonephritis was determined under the Veterans' Entitlements Act 1986 by the Repatriation Medical Authority in 2001. This Statement of Principles addresses the issue of mesangial IgA glomerulonephritis and death from this condition in veterans, providing a framework for the recognition and potential compensation of such conditions when related to their service. The Repatriation Medical Authority concluded that, based on the available medical-scientific evidence, it is more probable than not that mesangial IgA glomerulonephritis and death from this condition can be linked to relevant military service. The policy objective is to ensure that veterans who have contracted or experienced aggravation of this kidney disease due to their service are appropriately acknowledged and supported. This legislative instrument aims to bridge the gap in recognition and compensation for veterans suffering from this specific condition, ensuring that their service-related health issues are addressed with the necessary medical and financial support.

Scope and Application

The Veterans’ Entitlements Act 1986, as amended, provides the legislative framework for the Statement of Principles concerning Mesangial IgA Glomerulonephritis, which is specifically determined by the Repatriation Medical Authority. This Statement applies to veterans or members of the Armed Forces who have contracted mesangial IgA glomerulonephritis or have died from this condition, where there is a nexus to their service. Mesangial IgA glomerulonephritis is defined as a kidney disease characterised by specific histological features and clinical symptoms such as haematuria or proteinuria. The legislation identifies particular factors that must be related to the person’s service to establish a connection between the disease and their military service. For instance, in the case of secondary mesangial IgA glomerulonephritis, the presence of cirrhosis of the liver or Schonlein-Henoch purpura at the onset of the disease can be critical factors. Furthermore, the inability to obtain appropriate clinical management for the condition is another relevant factor. This Statement of Principles is inclusive of other related injuries or diseases as per existing Statements of Principles. The jurisdictional reach of this legislation is national, applying to veterans across Australia, and it is subject to the conditions and definitions set out in the Act and this specific legislative instrument.

Key Provisions

This legislative instrument, Determination of Statement of Principles concerning Mesangial IgA Glomerulonephritis, under the Veterans’ Entitlements Act 1986 (section 196B(3)), establishes criteria for linking mesangial IgA glomerulonephritis, a kidney disease characterised by IgA deposits in the renal mesangium, to service rendered by veterans or members of the armed forces (section 2). The determination considers it more probable than not that this condition can be related to relevant service, defined as eligible war service (other than operational service) or defence service (other than hazardous service) (section 3). For the condition to be connected with service, at least one of the specified factors must apply (section 4), such as suffering from cirrhosis of the liver or Schonlein-Henoch purpura at the onset of the disease for secondary mesangial IgA glomerulonephritis, or inability to obtain appropriate clinical management (section 5). The inability to obtain appropriate clinical management applies only to material contribution to, or aggravation of, the condition where the disease was contracted before or during service (section 6). This Statement of Principles also incorporates factors from other related Statements of Principles if applicable (section 7). The Act imposes obligations on veterans or members of the armed forces to provide evidence of their relevant service and the onset and progression of mesangial IgA glomerulonephritis. They must demonstrate that their condition meets the criteria outlined in the Statement of Principles, including any required factors such as cirrhosis of the liver or Schonlein-Henoch purpura, to establish a connection to their service. Additionally, if the condition was contracted before or during service, they must show that their inability to obtain appropriate clinical management materially contributed to or aggravated their condition. The Statement of Principles does not explicitly outline offences, penalties, or consequences for breach within the text provided. However, under the general provisions of the Veterans’ Entitlements Act 1986, any fraudulent claims or misrepresentations made in connection with entitlements could potentially lead to civil or criminal penalties. For example, knowingly making a false statement or providing false information could result in penalties under the relevant sections of the Act. The specific consequences would depend on the nature and severity of the breach, and any applicable penalties would be determined in accordance with the Act’s provisions.

Legal classification tags

Area of Law
Veterans’ Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Reporting & Disclosure Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.